Business · retail-expansion

MÜV opens new medical cannabis dispensary in Daytona Beach

AltMed Florida's MÜV brand adds another storefront to its Florida footprint, extending a retail strategy built on vertical integration and a medical-only patient base.

By Kira Mantel, Markets & Business ReporterPublished November 14, 20263 min read
Macro image of cannabis buds accompanied by rolling paper on a dark surface.

Macro image of cannabis buds accompanied by rolling paper on a dark surface.

MÜV, the Florida medical marijuana brand operated by AltMed Florida, opened a new dispensary in Daytona Beach on Nov. 13, 2026, adding another storefront in a medical-only market where license-bound operators expand mainly by building out retail.

What opened, and what's still unconfirmed

MÜV added a Daytona Beach dispensary, according to a Yahoo report published Nov. 13, 2026. The signal confirms the opening and the medical-only format. It doesn't supply a street address, a store count, capex, or a first-year revenue target.

We aren't going to guess at those. MÜV is the retail brand of AltMed Florida, and the company hasn't disclosed per-store economics in anything we reviewed. Nothing here is audited.

Location matters, and the reason is simple. Volusia County sits between the Orlando and Jacksonville patient pools, and Daytona Beach carries heavy seasonal and tourist traffic. But medical cards aren't tourist products. The real draw is year-round residents and retirees.

The Florida retail math

Florida's medical market rewards operators who control cultivation, processing and retail under one license. That's the vertical-integration requirement written into state law, and it shapes every expansion decision a licensed medical marijuana treatment center (MMTC) makes.

For a licensee, the storefront is the margin. Wholesale is largely a closed loop, so every new location pulls product through the company's own cultivation and processing at retail prices. More doors mean higher utilization of fixed-cost grow capacity. Investors in public Florida operators apply that per-share logic, and a privately held operator follows the same one, just with a different scorecard.

The opening reads as a utilization play: each additional Florida storefront spreads fixed cultivation and processing costs across a larger retail base.

Expansion isn't free, though. Build-out, staffing and local zoning all hit EBITDA before a new store ramps. Early-period dispensary margins typically lag mature stores, and Florida's price compression over the past few years has narrowed the cushion.

Competitive read-through and what to watch

The Daytona Beach opening puts MÜV in a crowded field of vertically integrated Florida licensees racing to saturate mid-sized metros. Competitors including Trulieve (TCNNF), Curaleaf (CURLF), Green Thumb and Cresco's Sunnyside have all pursued density in the state.

One store working isn't the question for MÜV. The question is whether the footprint can reach the scale needed to defend patient share against larger multi-state operators with bigger marketing budgets.

Three variables decide that:

  • Patient-count growth under the state's medical program
  • Pricing pressure in flower and vape categories
  • Any shift in Florida's adult-use politics, which would reorder the whole retail map

For full background on the state's program and its licensing structure, see the CannIntel topic hub on the Florida Medical Marijuana Program. The Florida Department of Health's Office of Medical Marijuana Use oversees patient registration and licensee compliance.

Watch for two things next: additional openings disclosed by MÜV, or state patient-registry data showing Volusia County growth outpacing the statewide average.

Sources

MÜVAltMed FloridaFlorida medical marijuanaDaytona Beachdispensary expansionvertical integration
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Business

More from the newsroom